Ascendis Pharma A (ASND) Divestments (2021 - 2025)

Ascendis Pharma A (ASND) reported Divestments of $526074.8 for Q3 2025, up 195.23% on a YoY basis from $178189.3 in Q3 2024, and up 195.23% sequentially from -$552404.4 in Q3 2024.

Ascendis Pharma A (ASND) Divestments (2021 - 2025) Analysis & Trends

Ascendis Pharma A (ASND) has 5 years of Divestments data on file, last reported at $526074.8 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -32.58 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Ascendis Pharma A 15.35 Bn 14.68 Bn 268.20 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 526,074.79
Sep 30, 2024 -552,404.41
Jun 30, 2023 51.13 Mn
Mar 31, 2023 226.10 Mn
Sep 30, 2022 14.22 Mn
Jun 30, 2022 10.55 Mn
Mar 31, 2022 43.26 Mn
Sep 30, 2021 24.09 Mn
Jun 30, 2021 13.29 Mn
Mar 31, 2021 -36.33 Mn